Vietnam's COVID-19 vaccine set to begin phase 3 trials in June

Vietnam’s domestically developed COVID-19 vaccine, Nano Covax, will begin Phase 3 of clinical trials in June involving up to 13,000 volunteers.
Vietnam's COVID-19 vaccine set to begin phase 3 trials in June ảnh 1Illustrative image (Photo: VNA)
Hanoi (VNS/VNA) - Vietnam’s domestically developed COVID-19 vaccine, NanoCovax, will begin Phase 3 of clinical trials in June involving up to 13,000volunteers.

Thisfollows promising results seen in the first two phases.

TheNational Ethics Committee in Biomedical Research under the Ministry of Healthsaid it has agreed in principle for the final phase in human trials of thesub-unit vaccine based on recombinant DNA/proteintechnology developed by Ho Chi Minh City-based biopharmaceutical companyNanogen.

Researchersneed to submit some more documents this week for the ministry to review andofficially greenlight the trials.

Phase3 will be divided into smaller segments – with the first involving some800-1,000 registered volunteers and will gradually expand to larger groups infuture segments. The Vietnam Military Academy in Hanoi and Hung Yen province’shealth authorities in the north, along with and HCM City Pasteur Institute andLong An province’s health authorities will help administer the vaccines involunteers and monitor responses.

Theoptimal dosage for the phase 3 will be 25mcg. All three dosages of 25mcg,50mcg, and 75mcg of the vaccine trialled in the first two phases providedlargely similar level of immune responses against coronavirus (SARS-CoV-2) sothe committee chose the lowest dosage to save on materials.

Phase2 of human trials, involved 554 people including 108 elderly, wascompleted on April 8 this year but monitoring of the volunteers’ health foreffectiveness and potential side effects could last up to a year. So farthe results have been quite promising, the committee said.

Theimmune response increased by 60 times 35 days after the first shot in somevolunteers, and the protection level remains at 34 times the normal level afterthree months.

Allvolunteers injected with the jabs produced immune response against the virus.

Thevaccine has the capacity to generate neutralising antibodies against theoriginal version of coronavirus first found in China’s Wuhan as well as mutantvariants first identified in South Africa during phase 2 trials, but morestudies in phase 3 are needed to clarify how effective it could be against theIndian variant that is wreaking havoc across the northern region of Vietnam inthe fourth wave of infections.

Afterinjection, volunteers exhibited symptoms such as pain at the injectionpoint, light fever, muscle aches, joint pain, and fatigue, which aretypical post-injection reactions. However they did not require medicalintervention.

Ifthings go well, phase 3 trials could conclude by the end of September andcommercial production could start soon after.

Therehave been talks earlier this week about using Nano Covax on a wider scalein case of severe outbreaks, similar to how Russia's Spunit V, the world'searliest COVID-19 vaccine to be approved and still one of the mosteffective, is administered on general population when data from phase 3have not been fully available.

Laodong (Labour)newspaper, citing a ‘reliable source,’ said that Nano Covax has receivedmillions of dollars in financial donations from a domestic conglomerate for thethird phase of trials and eventual inoculation of the country of near 100million-strong population to achieve vaccination goals within this year,helping to open up the economy and re-enable travel and tourism.

Thesupport also extended to ramping up of production capacity in order to meet thedomestic demands as well as possible exports of Nano Covax vaccines.

NguyenNgo Quang, Deputy Director of the Department of Science, Technology andTraining under the health ministry, said if Vietnam could have its ownmanufacturing technology domestically then it would be easier to evaluate andadjust the vaccines in cases of new variants.

DeputyPrime Minister Vu Duc Dam, 58, head of the National Steering Committee forCOVID-19 Prevention and Control, along with Deputy Minister of Science and TechnologyPham Cong Tac, 59, received two full doses of Nano Covax as part of the trials.

Theprice for each dose was projected to be 120,000 VND (5.2 USD). The doses aregiven intramuscularly with the spacing between each dose about a month (28days), according to Nanogen.

Anotherdomestic vaccine contender, Covivac by Institute of Vaccines and BiologicalMedical (IVAC) in Nha Trang city is preparing phase 1 trial’s data to bereviewed by the health ministry and could start phase 2 around late June-earlyJuly if the results are deemed acceptable.

Anotherlocally developed COVID-19 vaccine by Vabiotech is in preclinical trialson animals, and another from Polyvac (Centre for Research and Productionof Vaccines and Biologicals, under the health ministry) is still researching inlabs.

Polyvacsaid it is in talks with Russia’s relevant parties for technology transfer ofSputnik V (already approved for emergency use in Vietnam) for commercialproduction domestically later this year./.
VNA

See more

Male plastic surgery: Why masculine aesthetics require a different approach

Male plastic surgery: Why masculine aesthetics require a different approach

Plastic surgery has long been associated with procedures for women, but men also seek treatment for abdominal fat, enlarged breasts and age-related changes around the eyes and face. The American Society of Plastic Surgeons (ASPS) includes liposuction, gynecomastia surgery and eyelid surgery among procedures performed on male patients.

A speaker delivers presentations at the conference (Photo published by VNA)

Vietnam, Denmark expand cooperation in high-tech healthcare

Ambassador Nguyen Le Thanh called on Vietnamese and Danish partners to identify priority areas and promote research and training programmes, knowledge transfer and technology application in line with Politburo's Resolution No. 57-NQ/TW on breakthroughs in science – technology development, innovation and national digital transformation.

Ho Chi Minh City has favourable conditions for developing the ecosystem, including a large population, diverse healthcare needs and an extensive public and private medical network. (Illustrative photo: VNA)

Ho Chi Minh City develops multi-tier elderly care network amid population ageing

Dr. Huynh Minh Chin, Deputy Director of the department, said rising elderly care needs are putting pressure on traditional family-based care, as older people increasingly face multiple chronic illnesses, mobility problems, malnutrition, dementia and depression, requiring continuous support and closer coordination among hospitals, grassroots healthcare facilities, families and social support institutions.

Local residents in Mondulkiri province, Cambodia, receive free medical check-ups and health consultation. (Photo: VNA)

Free medical examinations provided to remote communities in Cambodia

Vietnamese Ambassador Nguyen Minh Vu said the programme has been jointly organised by the embassy and the hospital annually in various Cambodian localities to provide healthcare support to disadvantaged households and contribute to the Cambodian Government’s efforts to improve public health. The initiative also reflects close cooperation in healthcare and the strong bonds between the people of Vietnam and Cambodia.

With the assistance of robotic-assisted laparoscopic surgery, doctors successfully perform a complex operation (Photo: VNA)

Vietnam advances towards high-quality, specialised healthcare

Recent developments in Hanoi and other localities highlight efforts to develop specialised treatment, standardise professional practices and apply artificial intelligence (AI) and advanced medical techniques, towards a more modern healthcare system.

Collecting a sample from a pediatric patient for influenza testing (Photo: VNA)

Ho Chi Minh City acute respiratory infections surge over 64%

According to the Ho Chi Minh City Centre for Disease Control (HCDC), influenza viruses are are among the fastest-rising pathogens, with 151 positive samples in a single week. Influenza A is the dominant strain, with A/H1N1pdm09 in 116 samples, or nearly 77%.

A doctor at Trung Nguyen Medical Station in Te Lo commune, Phu Tho province, examines a child patient. (Photo: VNA)

Phu Tho builds hospital culture to improve patient satisfaction

In recent years, alongside efforts to improve the quality of medical examinations and treatment, Phu Tho province’s health sector has focused on creating civilised, friendly hospital environments and strengthening healthcare workers’ sense of responsibility and service-oriented attitudes, with the aim of earning patients’ trust and satisfaction.